Silicon Valley-based insulin delivery startup Bigfoot Biomedical has raised $37 million in funding. Janus Henderson Investors and Quadrant Capital Advisors led the round with participation from return backers Cormorant Asset Management, Senvest Capital Inc., Senvest Management LLC, Visionnaire Ventures, JDRF T1D Fund and T1D Exchange.